Hemogenyx Pharmaceuticals (HEMO) Share Price

Health Care Sector

  1. Home
    2. /
  2. Company
    3. /
  3. Hemogenyx Pharmaceuticals

NOTE: This is based on 1 open tips for Hemogenyx Pharmaceuticals (HEMO)


Hemogenyx Pharmaceuticals (HEMO)
Latest Quote Price

1.57p

Hemogenyx Pharmaceuticals (HEMO)
Price Change (%)

-1.25%


Latest Bid : 1.55p Latest Ask : 1.60p
High Today : 1.62p Low Today : 1.55p
This Years High : 3.96p This Years Low : 1.17p
Volume : 2,547,370 MKT Cap : £21.46M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only


Hemogenyx Pharmaceuticals (HEMO) Overview

Hemogenyx Pharmaceuticals Plc is a biotechnology company developing novel therapies to transform bone marrow and blood stem cell transplantation, announces the readmission of its enlarged issued share capital to the standard listing segment of the Official List and to trading on the main market for listed securities of the London Stock Exchange. The Company is the holding company for Hemogenyx LLC, a US-based biotechnology company developing therapies to transform bone marrow and blood stem cell transplantation. These therapies will replace the need for existing methods of preparation of patients for a transplantation such as chemotherapy and radiation treatments, and will address the problem of finding a matching stem cell donor and reduce the risk of blood stem cell rejection after transplantation.

Hemogenyx Pharmaceuticals (HEMO) Latest Tips

Type Tipster SectorScore Start date Performance
Buy Align Research Team Premium Only 2018-03-01 09:05:00 01/03/2018 -39.31%

Premium Content

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Hemogenyx Pharmaceuticals (HEMO) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 1.55p Latest Ask : 1.60p
High Today : 1.62p Low Today : 1.55p
This Years High : 3.96p This Years Low : 1.17p
Volume : 2,547,370 MKT Cap : £21.46M

Hemogenyx Pharmaceuticals Overview

Hemogenyx Pharmaceuticals Plc is a biotechnology company developing novel therapies to transform bone marrow and blood stem cell transplantation, announces the readmission of its enlarged issued share capital to the standard listing segment of the Official List and to trading on the main market for listed securities of the London Stock Exchange. The Company is the holding company for Hemogenyx LLC, a US-based biotechnology company developing therapies to transform bone marrow and blood stem cell transplantation. These therapies will replace the need for existing methods of preparation of patients for a transplantation such as chemotherapy and radiation treatments, and will address the problem of finding a matching stem cell donor and reduce the risk of blood stem cell rejection after transplantation.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Hemogenyx Pharmaceuticals Tips

Type Tipster SectorScore Start date Performance
Buy Align Research Team Premium Only 2018-03-01 09:05:00 01/03/2018 -39.31%